Medpace Holdings, Inc.
MEDP
$332.81
$7.082.17%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.61% | 0.99% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.61% | 0.99% | |||
| Cost of Revenue | -2.34% | 0.00% | |||
| Gross Profit | 2.02% | 1.46% | |||
| SG&A Expenses | -7.69% | 18.73% | |||
| Depreciation & Amortization | -0.16% | 3.91% | |||
| Other Operating Expenses | -1.05% | -4.91% | |||
| Total Operating Expenses | -2.34% | -0.45% | |||
| Operating Income | 11.67% | 6.77% | |||
| Income Before Tax | 12.72% | 7.51% | |||
| Income Tax Expenses | -24.55% | 0.99% | |||
| Earnings from Continuing Operations | 21.36% | 9.14% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 21.36% | 9.14% | |||
| EBIT | 11.67% | 6.77% | |||
| EBITDA | 10.93% | 6.59% | |||
| EPS Basic | 21.75% | 8.94% | |||
| Normalized Basic EPS | 13.09% | 7.31% | |||
| EPS Diluted | 22.04% | 9.45% | |||
| Normalized Diluted EPS | 13.48% | 7.50% | |||
| Average Basic Shares Outstanding | -0.33% | 0.18% | |||
| Average Diluted Shares Outstanding | -0.67% | 0.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
